Valuation: Shockwave Medical

Market Cap 12.57B 10.94B 10.33B 9.38B 17.58B 1,205B 17.66B 124B 47.71B 613B 47.21B 46.16B 1,971B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 12.35B 10.75B 10.15B 9.22B 17.27B 1,184B 17.35B 121B 46.88B 602B 46.38B 45.35B 1,937B EV / Sales 2025 *
-
EV / Sales 2026 * -
Free-Float
-
Yield 2025 *
-
Yield 2026 * -
1 day-0.01%
1 week+0.01%
Current month+0.01%
1 month+0.01%
3 months+0.01%
6 months+0.01%
Current year+0.01%
3 years 157
Extreme 157
334.9
5 years 113.36
Extreme 113.36
334.9
10 years 22.01
Extreme 22.01
334.9
Manager TitleAgeSince
Director of Finance/CFO 48 31/05/2024
President 51 01/11/2018
Chief Tech/Sci/R&D Officer 58 -
Director TitleAgeSince
Director/Board Member - 31/05/2024
Director/Board Member - 31/05/2024
Director/Board Member - 31/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
5/31/24 A Issuer sale

Director

106,226 0.2833%
5/31/24 A
Sofinnova Partners SAS
Issuer saleCompany 34,177 0.0911%
5/31/24 A Issuer sale

Director

33,969 0.0906%
Change 5-day change 1-year change 3-year change Capi.($)
-0.01%+0.01%+0.01%+58.50% 12.57B
-0.40%-0.04%+23.22%+21.11% 12.51B
-1.05%+0.77%+11.94%+16.93% 6.52B
-1.09%-3.16% - - 6.12B
-0.21%+2.66%+23.70%+10.27% 5.54B
-1.53%-1.17%-20.99%+35.65% 4.99B
+0.38%+3.39%-31.74%-24.86% 3.9B
-0.18%+7.61%+28.38%-11.32% 1.94B
-1.65%-2.30%-18.13%+191.44% 1.71B
-1.95%+2.06%+45.86%-17.74% 1.57B
Average -0.77%+0.70%+6.92%+31.11% 5.74B
Weighted average by Cap. -0.56%+0.14%+7.17%+29.77%

Financials

2025 *2026 *
Net sales - -
Net income - -
Net Debt - -
Logo Shockwave Medical
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
Employees
1,468
  1. Stock Market
  2. Stocks
  3. SWAV Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!